Nuclidium
Nuclidium: copper-based drugs for precise cancer care
NUCLIDIUM AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Nuclidium
Nuclidium: copper-based drugs for precise cancer care
Website:
nuclidium.com/
Headquarter:
Basel
Technology:
- Medtech